Year: 2015
Type: article
Abstract: Distal symmetric sensorimotor polyneuropathy (DSPN) is the most common neurological manifestation in diabetes. Major risk factors of DSPN include diabetes duration, hyperglycemia, and age, followed by prediabetes, hypertension, dyslipidemia, and obesity. Height, smoking, insulin resistance, hypoinsulinemia, and others represent an additional risk. Importantly, hyperglycemia, hypertension, dyslipidemia, obesity, and smoking are modifiable. Stringent glycemic control has been shown to be effective in type 1, but not to the same extent in type 2 diabetes. Antilipidemic treatment, especially with fenofibrate, and multi-factorial intervention have produced encouraging results, but more experience is necessary. The major comorbidities of DSPN are depression, autonomic neuropathy, peripheral arterial disease, cardiovascular disease, nephropathy, retinopathy, and medial arterial calcification. Knowledge of risk factors and comorbidities has the potential to enrich the therapeutic strategy in clinical practice as part of the overall medical care for patients with neuropathy. This article provides an updated overview of DSPN risk factors and comorbidities.
Source: The Review of Diabetic Studies
Authors: Nikolaos Papanas, Dan Ziegler
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: diabetic neuropathy, risk factors, comorbidities, hyperglycemia, diabetes duration, prediabetes, hypertension, dyslipidemia, obesity, smoking, insulin resistance, glycemic control, fenofibrate, depression, autonomic neuropathy, peripheral arterial disease, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, medial arterial calcification, type 1 diabetes, type 2 diabetes
Open Access status: hybrid
OpenAlex ID: W2204676649
